Establishment Labs Holdings, Inc. (ESTA)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Establishment Labs Holdings, Inc. (ESTA)
Company Performance

Current Price

as of Oct 16, 2024

$42.91

P/E Ratio

N/A

Market Cap

$1.2B

Description

Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.

Metrics

Overview

  • HQCoyol, AL
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerESTA
  • Price$42.91+0.89%

Trading Information

  • Market Cap$1.20B
  • Float88.35%
  • Average Daily Volume (1m)596,710
  • Average Daily Volume (3m)366,813
  • EPS-$3.11

Company

  • Revenue$151.35M
  • Rev Growth (1yr)-9.15%
  • Net Income-$17.18M
  • Gross Margin65.59%
  • EBITDA Margin-17.59%
  • EBITDA-$7.76M
  • EV$1.41B
  • EV/Revenue9.32
  • P/EN/A
  • P/S7.91
  • P/B26.63
Documents
SEC Filings
8-K (2024-09-26)
8-K (2024-08-26)
8-K (2024-08-06)
8-K (2024-07-16)
8-K (2024-06-05)
8-K (2024-05-28)
8-K (2024-05-08)
8-K (2024-04-02)
8-K (2024-02-28)
8-K (2024-02-22)
8-K (2024-01-31)
8-K (2024-01-09)
8-K (2023-12-14)
8-K (2023-11-07)
8-K (2023-08-08)
8-K (2023-05-31)
8-K (2023-05-08)
8-K (2023-04-27)
8-K (2023-04-24)
8-K (2023-04-20)
8-K (2023-02-27)
8-K (2023-01-11)
8-K (2023-01-09)
10-Q (2024-08-07)
10-Q (2024-05-09)
10-Q (2023-11-08)
10-Q (2023-08-09)
10-Q (2023-05-10)
10-K (2024-03-04)
10-K (2023-03-01)
Earnings Calls
Earnings Report 2024Q2
Earnings Report 2024Q1
Earnings Report (2023-11-07)
Earnings Report (2023-08-09)
Factset Street Account
Establishment Labs Holdings reports Q3 EPS ($1.12) vs FactSet ($0.80) [7 est, ($1.02)-(0.61)] ($33.20, 0.00) (2023-11-07T21:03:33Z)
Establishment Labs Holdings pares declines following BTIG note indicating China NMPA approved Motiva implants ($27.28, -5.43) (2023-11-08T20:46:26Z)
Establishment Labs confirms approval of Motiva implants by China's NMPA ($25.12, 0.00) (2023-11-09T13:08:52Z)
Establishment Labs announces two-year Mia Femtech clinical results and launch of Zen at WSEI ($33.34, 0.00) (2023-10-13T12:07:15Z)